BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niu F, Liu Y, Jing Z, Han G, Sun L, Yan L, Zhou L, Wu Y, Xu Y, Hu L, Zhao X. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma. Cancer Lett 2018;420:60-71. [PMID: 29408653 DOI: 10.1016/j.canlet.2018.01.066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Sun S, Guo H. Current status of carbazole hybrids as anticancer agents. Eur J Med Chem 2021;:113999. [PMID: 34838335 DOI: 10.1016/j.ejmech.2021.113999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Sinicropi MS, Tavani C, Rosano C, Ceramella J, Iacopetta D, Barbarossa A, Bianchi L, Benzi A, Maccagno M, Ponassi M, Spinelli D, Petrillo G. A Nitrocarbazole as a New Microtubule-Targeting Agent in Breast Cancer Treatment. Applied Sciences 2021;11:9139. [DOI: 10.3390/app11199139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Malarz K, Mularski J, Kuczak M, Mrozek-Wilczkiewicz A, Musiol R. Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest. Cancers (Basel) 2021;13:1790. [PMID: 33918637 DOI: 10.3390/cancers13081790] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Javid N, Munir R, Chaudhry F, Imran A, Zaib S, Muzaffar A, Iqbal J. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. Bioorganic Chemistry 2020;99:103852. [DOI: 10.1016/j.bioorg.2020.103852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Liu Y, Wu Y, Sun L, Gu Y, Hu L. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents. Eur J Med Chem 2020;191:112181. [PMID: 32113125 DOI: 10.1016/j.ejmech.2020.112181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
6 Issa S, Prandina A, Bedel N, Rongved P, Yous S, Le Borgne M, Bouaziz Z. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. J Enzyme Inhib Med Chem 2019;34:1321-46. [PMID: 31328585 DOI: 10.1080/14756366.2019.1640692] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
7 Wang H, Yang X, Guo Y, Shui L, Li S, Bai Y, Liu Y, Zeng M, Xia J. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. J Exp Clin Cancer Res. 2019;38:324. [PMID: 31331361 DOI: 10.1186/s13046-019-1284-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhao Y, Huang X, Liu L, Wang P, Long Q, Tao Q, Li Z, Yang S. Identification of Racemic and Chiral Carbazole Derivatives Containing an Isopropanolamine Linker as Prospective Surrogates against Plant Pathogenic Bacteria: In Vitro and In Vivo Assays and Quantitative Proteomics. J Agric Food Chem 2019;67:7512-25. [DOI: 10.1021/acs.jafc.9b02036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]